Microcurrent Stimulation Therapy for Age-Related Macular Degeneration
(i-SIGHT2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to characterize the safety and effectiveness of the i-Lumen AMD transpalpebral microcurrent device and therapy in patients with intermediate to advanced nonexudative AMD.
Participants will:
* Undergo an initial loading regimen, followed by 7 maintenance over the course of 11 months.
* Participants will return monthly through Month 14 (3 months post-last treatment) for evaluation and monitoring.
Who Is on the Research Team?
Meredith Mundy
Principal Investigator
i-Lumen Scientific AUS PTY LTD
Are You a Good Fit for This Trial?
Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- i-Lumen AMD
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Active transpalpebral microcurrent therapy
Sham transpalpebral microcurrent therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
i-Lumen Scientific AUS PTY LTD
Lead Sponsor
i-Lumen Scientific, Inc.
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.